Steven Cohen’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.5M Buy
335,108
+205,925
+159% +$2.28M ﹤0.01% 2036
2026
Q2
$1.33M Buy
129,183
+21,972
+20% +$166K ﹤0.01% 2654
2026
Q1
$525K Buy
+107,211
New +$583K ﹤0.01% 3096
2022
Q4
– Sell
-403,131
Closed -$1.27M – 1527
2022
Q3
$1.27M Sell
403,131
-339,951
-46% -$1.15M 0.01% 1014
2022
Q2
$2.41M Buy
+743,082
New +$2.98M 0.01% 894

Other funds holding CADL

Steven Cohen's CADL Position: Q3 2026 in Review

Steven Cohen increased its Candel Therapeutics (CADL) stake by 159% in Q3 2026, buying an estimated $2.28M and bringing the position to 335,108 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Steven Cohen first reported a position in CADL in Q2 2022 and has held it in 5 quarters since. 140 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

  • Steven Cohen held 335,108 shares of Candel Therapeutics worth $3.5M as of Q3 2026.
  • Steven Cohen bought 205,925 Candel Therapeutics shares in Q3 2026, an estimated $2.28M.
  • Candel Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2036 holding.
  • Steven Cohen first reported a position in Candel Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • 140 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.